MedPath

Intervention study to evaluate the efficacy of etelcalcetide and cinacalcet on bone and mineral disorders in hemodialysis patient.

Not Applicable
Conditions
Hemodialysis patients treated with cinacalcet for secondary hyperparathyroidism
Registration Number
JPRN-UMIN000029155
Lead Sponsor
Kawashima hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

The patient judged low adherence was and additionally.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath